[1]
Gentilini, F. et al. 2012. Bortezomib a safety treatment for patients with Multiple Myeloma and Cystic Fibrosis. Mediterranean Journal of Hematology and Infectious Diseases. 4, 1 (May 2012), e2012035. DOI:https://doi.org/10.4084/mjhid.2012.035.